KURA: Kura Oncology Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Kura Oncology Inc (KURA).
$677.32M Market Cap.
KURA Market Cap. (MRY)
KURA Shares Outstanding (MRY)
KURA Assets (MRY)
Total Assets
$760.16M
Total Liabilities
$346.52M
Total Investments
$502.93M
KURA Income (MRY)
Revenue
$53.88M
Net Income
-$173.98M
Operating Expense
$247.08M
KURA Cash Flow (MRY)
CF Operations
$134.32M
CF Investing
-$101.59M
CF Financing
$154.42M
KURA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $760,159,000 (69.32%) | $448,935,000 (-1.62%) | $456,306,000 (-14.56%) | $534,051,000 (-17.48%) |
Assets Current | $744,829,000 (72.22%) | $432,481,000 (-3.12%) | $446,426,000 (-14.53%) | $522,289,000 (-18.05%) |
Assets Non-Current | $15,330,000 (-6.83%) | $16,454,000 (66.54%) | $9,880,000 (-16.00%) | $11,762,000 (18.57%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $413,640,000 (4.12%) | $397,273,000 (-5.47%) | $420,278,000 (-17.04%) | $506,609,000 (-17.07%) |
Property Plant & Equipment Net | $7,485,000 (-15.44%) | $8,852,000 (38.70%) | $6,382,000 (-22.60%) | $8,246,000 (-1.30%) |
Cash & Equivalents | $224,462,000 (501.48%) | $37,318,000 (-27.96%) | $51,802,000 (-43.00%) | $90,882,000 (-72.10%) |
Accumulated Other Comprehensive Income | $764,000 (160.11%) | -$1,271,000 (84.18%) | -$8,032,000 (-348.97%) | -$1,789,000 (-3989.13%) |
Deferred Revenue | $253,906,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $502,933,000 (30.08%) | $386,639,000 (0.12%) | $386,183,000 (-9.62%) | $427,288,000 (38.81%) |
Investments Current | $502,933,000 (30.08%) | $386,639,000 (0.12%) | $386,183,000 (-9.62%) | $427,288,000 (38.81%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $2,060,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $49,953,000 (47.98%) | $33,757,000 (55.28%) | $21,739,000 (7.66%) | $20,192,000 (-12.30%) |
Accumulated Retained Earnings (Deficit) | -$895,422,000 (-24.12%) | -$721,439,000 (-26.83%) | -$568,808,000 (-31.37%) | -$432,968,000 (-43.13%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $16,594,000 (-3.52%) | $17,200,000 (22.65%) | $14,024,000 (103.99%) | $6,875,000 (-46.66%) |
Debt Current | $4,488,000 (198.01%) | $1,506,000 (-35.03%) | $2,318,000 (2.43%) | $2,263,000 (-24.57%) |
Debt Non-Current | $12,106,000 (-22.86%) | $15,694,000 (34.07%) | $11,706,000 (153.82%) | $4,612,000 (-53.36%) |
Total Liabilities | $346,519,000 (570.74%) | $51,662,000 (43.39%) | $36,028,000 (31.29%) | $27,442,000 (-24.42%) |
Liabilities Current | $78,712,000 (123.21%) | $35,263,000 (46.58%) | $24,057,000 (7.13%) | $22,455,000 (-13.71%) |
Liabilities Non-Current | $267,807,000 (1533.07%) | $16,399,000 (36.99%) | $11,971,000 (140.04%) | $4,987,000 (-51.50%) |
KURA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $53,883,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $77,111,000 (52.49%) | $50,569,000 (7.47%) | $47,053,000 (1.11%) | $46,537,000 (47.73%) |
Research & Development Expense | $169,967,000 (47.50%) | $115,235,000 (24.16%) | $92,812,000 (9.55%) | $84,721,000 (40.27%) |
Operating Expenses | $247,078,000 (49.02%) | $165,804,000 (18.55%) | $139,865,000 (6.56%) | $131,258,000 (42.83%) |
Interest Expense | $1,619,000 (4.52%) | $1,549,000 (576.42%) | $229,000 (-44.69%) | $414,000 (-28.37%) |
Income Tax Expense | $2,018,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$173,983,000 (-13.99%) | -$152,631,000 (-12.36%) | -$135,840,000 (-4.12%) | -$130,466,000 (-45.57%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$173,983,000 (-13.99%) | -$152,631,000 (-12.36%) | -$135,840,000 (-4.12%) | -$130,466,000 (-45.57%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$173,983,000 (-13.99%) | -$152,631,000 (-12.36%) | -$135,840,000 (-4.12%) | -$130,466,000 (-45.57%) |
Weighted Average Shares | $86,161,000 (17.66%) | $73,229,000 (9.31%) | $66,990,000 (0.96%) | $66,352,000 (25.01%) |
Weighted Average Shares Diluted | $86,161,000 (17.66%) | $73,229,000 (9.31%) | $66,990,000 (0.96%) | $66,352,000 (25.01%) |
Earning Before Interest & Taxes (EBIT) | -$170,346,000 (-12.75%) | -$151,082,000 (-11.41%) | -$135,611,000 (-4.27%) | -$130,052,000 (-46.05%) |
Gross Profit | $53,883,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$193,195,000 (-16.52%) | -$165,804,000 (-18.55%) | -$139,865,000 (-6.56%) | -$131,258,000 (-42.83%) |
KURA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$101,590,000 (-753.02%) | $15,557,000 (-52.32%) | $32,627,000 (125.72%) | -$126,835,000 (-26.92%) |
Net Cash Flow from Financing | $154,417,000 (62.92%) | $94,783,000 (145.77%) | $38,565,000 (1222.71%) | -$3,435,000 (-100.73%) |
Net Cash Flow from Operations | $134,317,000 (207.61%) | -$124,824,000 (-13.41%) | -$110,062,000 (-5.27%) | -$104,551,000 (-49.72%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $187,144,000 (1392.07%) | -$14,484,000 (62.74%) | -$38,870,000 (83.45%) | -$234,821,000 (-178.39%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$101,118,000 (-743.04%) | $15,725,000 (-52.71%) | $33,253,000 (126.46%) | -$125,688,000 (-28.56%) |
Capital Expenditure | -$472,000 (-180.95%) | -$168,000 (73.16%) | -$626,000 (45.42%) | -$1,147,000 (47.17%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $9,425,000 (219.90%) | -$7,861,000 (-3044.40%) |
Issuance (Purchase) of Equity Shares | $154,417,000 (62.92%) | $94,783,000 (225.27%) | $29,140,000 (558.38%) | $4,426,000 (-99.06%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $33,897,000 (20.71%) | $28,082,000 (6.70%) | $26,318,000 (11.62%) | $23,579,000 (84.11%) |
Depreciation Amortization & Accretion | $848,000 (-0.12%) | $849,000 (11.86%) | $759,000 (36.02%) | $558,000 (187.63%) |
KURA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% | - | - | - |
Profit Margin | -322.90% | - | - | - |
EBITDA Margin | -314.60% | - | - | - |
Return on Average Equity (ROAE) | -38.50% (-6.06%) | -36.30% (-17.86%) | -30.80% (-28.87%) | -23.90% (3.63%) |
Return on Average Assets (ROAA) | -30.20% (8.76%) | -33.10% (-14.14%) | -29.00% (-27.75%) | -22.70% (0.87%) |
Return on Sales (ROS) | -316.10% | - | - | - |
Return on Invested Capital (ROIC) | -37.20% (-1.92%) | -36.50% (-7.99%) | -33.80% (-27.07%) | -26.60% (28.30%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -4.31 (37.62%) | -6.91 (-13.09%) | -6.11 (13.99%) | -7.11 (63.22%) |
Price to Sales Ratio (P/S) | 13.93 | - | - | - |
Price to Book Ratio (P/B) | 1.64 (-39.10%) | 2.69 (36.10%) | 1.98 (7.40%) | 1.84 (-39.35%) |
Debt to Equity Ratio (D/E) | 0.84 (544.62%) | 0.13 (51.16%) | 0.09 (59.26%) | 0.05 (-8.47%) |
Earnings Per Share (EPS) | -2.02 (2.88%) | -2.08 (-2.46%) | -2.03 (-3.05%) | -1.97 (-16.57%) |
Sales Per Share (SPS) | 0.63 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | 1.55 (190.98%) | -1.71 (-3.33%) | -1.65 (-3.70%) | -1.59 (-17.39%) |
Book Value Per Share (BVPS) | 4.8 (-11.50%) | 5.42 (-13.53%) | 6.27 (-17.83%) | 7.63 (-33.67%) |
Tangible Assets Book Value Per Share (TABVPS) | 8.82 (43.91%) | 6.13 (-10.00%) | 6.81 (-15.37%) | 8.05 (-33.99%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (42.86%) | -7 (-40.00%) | -5 (28.57%) | -7 (65.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.8 (45.95%) | -7.03 (-27.43%) | -5.52 (20.36%) | -6.93 (65.57%) |
Asset Turnover | 0.09 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 9.46 (-22.84%) | 12.26 (-33.91%) | 18.56 (-20.22%) | 23.26 (-5.02%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $133,845,000 (207.08%) | -$124,992,000 (-12.92%) | -$110,688,000 (-4.72%) | -$105,698,000 (-46.80%) |
Enterprise Value (EV) | $644,471,263 (-39.01%) | $1,056,716,956 (41.95%) | $744,428,423 (-17.05%) | $897,490,850 (-49.82%) |
Earnings Before Tax (EBT) | -$171,965,000 (-12.67%) | -$152,631,000 (-12.36%) | -$135,840,000 (-4.12%) | -$130,466,000 (-45.57%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$169,498,000 (-12.82%) | -$150,233,000 (-11.41%) | -$134,852,000 (-4.14%) | -$129,494,000 (-45.74%) |
Invested Capital | $473,579,000 (20.33%) | $393,554,000 (-0.23%) | $394,471,000 (-7.75%) | $427,589,000 (38.66%) |
Working Capital | $666,117,000 (67.70%) | $397,218,000 (-5.95%) | $422,369,000 (-15.50%) | $499,834,000 (-18.23%) |
Tangible Asset Value | $760,159,000 (69.32%) | $448,935,000 (-1.62%) | $456,306,000 (-14.56%) | $534,051,000 (-17.48%) |
Market Capitalization | $677,322,263 (-36.58%) | $1,068,032,956 (28.65%) | $830,191,423 (-10.90%) | $931,780,850 (-49.69%) |
Average Equity | $452,141,250 (7.52%) | $420,517,750 (-4.73%) | $441,410,000 (-19.19%) | $546,225,750 (51.42%) |
Average Assets | $577,005,000 (25.20%) | $460,854,500 (-1.65%) | $468,576,000 (-18.52%) | $575,086,500 (46.87%) |
Invested Capital Average | $457,378,500 (10.47%) | $414,011,250 (3.17%) | $401,284,000 (-18.00%) | $489,365,250 (103.69%) |
Shares | 77,763,750 (4.70%) | 74,272,111 (11.02%) | 66,896,972 (0.51%) | 66,555,775 (17.37%) |
